Literatur
- 1
Galie N. et al .
Comparative analysis of clinical trials and evidence-based treatment algorithm
in pulmonary arterial hypertension.
J Am Coll Cardiol.
2004;
43
(12 Suppl S)
81S-88S
- 2
Ghofrani H A. et al .
Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary
hypertension.
Am J Respir Crit Care Med.
2003;
167
1139-1141
- 3
Olschewski H. et al .
Inhaled iloprost for severe pulmonary hypertension.
N Engl J Med.
2002;
347
322-329
- 4
Olschewski H. et al .
Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial
German PPH Study Group.
Ann Intern Med.
2000;
132
435-443
- 5
Rich S. et al .
The effect of high doses of calcium-channel blockers on survival in primary
pulmonary hypertension.
N Engl J Med.
1992;
327
76-81
- 6
Rubin L J. et al .
Bosentan therapy for pulmonary arterial hypertension.
N Engl J Med.
2002;
346
896-903
- 7
Sastry B K. et al .
Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized,
placebo-controlled, double-blind, crossover study.
J Am Coll Cardiol.
2004;
43
1149-1153
Priv.-Doz. Dr. Horst Olschewski
Medizinische Klinik II, der Universität Gießen
Klinikstraße 36
35392 Gießen
Email: Horst.Olschewski@innere.med.uni-giessen.de
